Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald P Levine

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|August 10, 2013
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditisRavina Kullar, Anthony M Casapao, Susan L Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2021
Validity of 2020 vancomycin consensus recommendations and further guidance for practical applicationMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2020
Questions on Vancomycin DosingMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Multicenter study of high-dose daptomycin for treatment of enterococcal infectionsAnthony M Casapao, Ravina Kullar, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKimberly C Claeys, Evan J Zasowski, Anthony M Casapao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2020
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summaryCatherine Liu, Arnold Bayer, Sara E Cosgrove, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2020
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Pharmacotherapy|April 1, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|August 10, 2013
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditisRavina Kullar, Anthony M Casapao, Susan L Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2021
Validity of 2020 vancomycin consensus recommendations and further guidance for practical applicationMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2020
Questions on Vancomycin DosingMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Multicenter study of high-dose daptomycin for treatment of enterococcal infectionsAnthony M Casapao, Ravina Kullar, Susan L Davis, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKimberly C Claeys, Evan J Zasowski, Anthony M Casapao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2020
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summaryCatherine Liu, Arnold Bayer, Sara E Cosgrove, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2020
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Pharmacotherapy|April 1, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases PharmacistsMichael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Pageof 5